Form 4 for DCGO DocGo Inc.
Accepted 2022-05-04 00:00:00 ET · period of report 2022-04-07 · accession 0001213900-22-023979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-04-07 | DCGO | Sugrue Stephen | CCO | M - OptEx | $3.25 | +16.1K | 16.1K | New | +$52.4K |
| D | 2022-05-04 | 2022-04-07 | DCGO | Sugrue Stephen | CCO | M - OptEx | $0.00 | -16.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | M | A | 16,128 | $3.25 | 16,128 | D | — | — | |
| 2 | Derivative | Option to Buy | 2022-04-07 | M | D | 16,128 | $0.00 | 0 | D | $3.25 · 2022-01-05 to 2031-01-07 | 16,128 Common Stock | (F1) The number of shares subject to this tranche has previously erroneously been reported as 16,129 on a Form 3 filed on March 21, 2022. It should have been reported as 16,128. Therefore, this tranche has been fully exercised. |